• en
  • pt

 

A Faculdade de Medicina da Universidade de Lisboa (FMUL) vai acolher, nos dias 5 a 7 de fevereiro de 2018, a XLVIII Reunião da Sociedade Portuguesa de Farmacologia, XXXVI Reunião de Farmacologia Clínica, e XVII Reunião de Toxicologia. Este encontro tem como principal objetivo a divulgação do progresso do conhecimento e da investigação nas áreas de Farmacologia, Farmacologia Clínica e Toxicologia. Contará com um programa científico de qualidade, onde os participantes terão a oportunidade de estabelecer novas colaborações e expandir conhecimentos. Juntos continuaremos a divulgar e inovar a farmacologia em Portugal. Convocamos a presença de todos os investigadores na área e encorajamos a participação de jovens investigadores para apresentação e discussão do trabalho que têm vindo a desenvolver.

As sessões são abertas à comunidade científica, incluindo alunos.

Contará com 3 lições plenárias por oradores internacionais de diferentes áreas: ensino da farmacologia (Simon Maxwell); neurofarmacologia da epilepsia (Detlev Boison) e empreendedorismo (Teresa Tarragó):

 

1) SynaNet Lecture

Monday | February 5th, 2018 Anfiteatro 52 do Edifício Egas Moniz, FMUL (11h:15-12h:15)

 

Teresa Tarragó – The Iproteos story: From bench to bedside

Teresa Tarragó has a PhD in Molecular Biology from the University of Barcelona. She has solid expertise in drug discovery, gained for 15 years spent conducting several research lines on proteases and protease inhibitors at the Spanish National Research Council (CSIC) and IRB Barcelona. She has experience in managing internationally-funded research projects, as well as directing joint undertakings with biotech companies. She has published over 40 papers and two books, and she holds four patents. In addition to her scientific qualifications, she holds an Executive MBA (ESADE) and has participated in entrepreneurship programmes, including “Ignite” at Cambridge Judge Business School and “BioEmprendedor XXI” (Barcelona).

……………………………………………………………………………………………………………………………………………………

2) EPHAR Lecture

Monday | February 5th, 2018 Grande Auditório João Lobo Antunes (14h:10- 15h:10)

 

Simon Maxwell – Preparing to prescribe medicines: delivering better training to the next generation of doctors

Simon Maxwell is Professor of Student Learning/Clinical Pharmacology and Director of Pharmacology & Therapeutics teaching at the University of Edinburgh, where he has been active in developing e-Learning strategies to support education in this area. His clinical responsibilities include supervision of acute medical admissions and the management of outpatients at increased cardiovascular risk. He is Chair of the British Pharmacological Society (BPS) Prescribing Committee and was lead author of the core curriculum for CPT teaching in UK medical schools. He is Chair of the European Association of CPT (EACPT) Education Committee and Secretary of the International Union of Pharmacology and Clinical Pharmacology (IUPHAR) Education Section. He has recently been a member of the NICE drug appraisals committee, is currently a member of the Scottish Medicines Consortium, the Medicine and Healthcare products Regulatory Agency’s (MHRA) Pharmacovigilance Expert Advisory Committee and is Medical Director of the Scottish Centre for Adverse Reactions to Drugs (CARDS). He was formerly Vice-President of the BPS and is a fellow of the Royal Colleges of Physicians in London and Edinburgh and of the Higher Education Academy. He is Clinical lead for the Prescribe project, a joint collaboration between the Department of Health, Medical Schools Council (MSC) and BPS to deliver a national eLearning solution to develop safe and effective prescribing amongst UK medical students. He is Medical Director of the Prescribing Skills Assessment, a joint initiative by the BPS and MSC to produce a national assessment of prescribing for all UK medical students. He is also part of an international group developing an electronic Summary of Product Characteristics (European 10 Medicine’s Agency) and a UK group tasked to develop unified prescribing documentation (Academy of Medical Royal Colleges). He is the author of more than 80 publications in international peer review journals.

 

……………………………………………………………………………………………………………………………………………………

3) SPF2018- Invited Lecture

Tuesday | February 6th, 2018 Grande Auditório João Lobo Antunes 9:00 (9h:00-10h:00)


Detlev Boison –  Intracellular adenosine – opportunities for epilepsy prevention

Detlev Boison obtained his Ph.D. in Biochemistry from the University of Cologne, Germany. Before joining the R.S. Dow Neurobiology Laboratories in 2005, he headed a research group at the University of Zurich, Switzerland, where he obtained his Habilitation (venia legendi) in cellular pharmacology. Nowadays, he is the Dow Chair of Neurology & Director of Neurobiology Research and Director of Basic and Translational Research at Legacy Health in Portland, Oregon. The focus of the Boison laboratory is the brain’s endogenous anticonvulsant and neuroprotectant adenosine. They try to understand how adenosine function and dysfunction contributes to normal and pathological brain function, respectively, and to translate these findings into novel therapeutic approaches. They study adenosine-related physiological and pathophysiological mechanisms in rodent models of disease and in mice with engineered mutations in adenosine metabolism or signaling. Bioengineered polymers, stem cell therapies, and gene therapies are used to afford therapeutic augmentation of the adenosine system. They apply these tools to study disease mechanisms and treatment options in epilepsy, traumatic brain injury, stroke, and schizophrenia. He is the author of more than 120 publications in international peer review journals.

Copyright 2018 | Faculdade de Medicina da Universidade de Lisboa |